Education
About Us
Working with TipRanks
Follow Us
IPCA Laboratories Limited (IN:IPCALAB)
:IPCALAB
Total Valuation
IPCA Laboratories Limited has a market cap or net worth of ₹356.89B. The enterprise value is ₹397.84B.
Market Cap₹356.89B
Enterprise Value₹397.84B
Share Statistics
IPCA Laboratories Limited has 253,659,230 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding253,659,230
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
IPCA Laboratories Limited’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 25.14%.
Return on Equity (ROE)0.11
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)25.14%
Return on Capital Employed (ROCE)0.39
Revenue Per Employee5.16M
Profits Per Employee425.54K
Employee Count17,335
Asset Turnover0.76
Inventory Turnover1.20
Valuation Ratios
The current PE Ratio of IPCA Laboratories Limited is 42.9. IPCA Laboratories Limited’s PEG ratio is 1.37.
PE Ratio42.9
PS Ratio3.95
PB Ratio5.08
Price to Fair Value5.08
Price to FCF70.64
Price to Operating Cash Flow0.00
PEG Ratio1.37
Income Statement
In the last 12 months, IPCA Laboratories Limited had revenue of 89.41B and earned 7.38B in profits. Earnings per share was 29.08.
Revenue89.41B
Gross Profit58.60B
Operating Income36.66B
Pretax Income11.29B
Net Income7.38B
EBITDA16.67B
Earnings Per Share (EPS)29.08
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
IPCA Laboratories Limited pays an annual dividend of ₹2, resulting in a dividend yield of 0.28%
Dividend Per Share₹2
Dividend Yield0.28%
Payout Ratio9.80%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.65
52-Week Price Change-7.76%
50-Day Moving Average1.34K
200-Day Moving Average1.39K
Relative Strength Index (RSI)55.35
Average Volume (3m)6.78K
Important Dates
IPCA Laboratories Limited upcoming earnings date is Feb 18, 2026, TBA (Confirmed).
Last Earnings DateNov 13, 2025
Next Earnings DateFeb 18, 2026
Ex-Dividend DateAug 05, 2025
Financial Position
IPCA Laboratories Limited as a current ratio of 2.50, with Debt / Equity ratio of 0.00%
Current Ratio2.50
Quick Ratio1.43
Debt to Market Cap0.04
Net Debt to EBITDA0.72
Interest Coverage Ratio41.74
Taxes
In the past 12 months, IPCA Laboratories Limited has paid 3.44B in taxes.
Income Tax3.44B
Effective Tax Rate0.30
Enterprise Valuation
IPCA Laboratories Limited EV to EBITDA ratio is 21.89, with an EV/FCF ratio of 73.03.
EV to Sales4.08
EV to EBITDA21.89
EV to Free Cash Flow73.03
EV to Operating Cash Flow28.61
Balance Sheet
IPCA Laboratories Limited has ₹11.05B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of ₹11.05B billion.
Cash & Marketable Securities₹11.05B
Total Debt₹0.00
Net Cash₹11.05B
Net Cash Per Share₹43.56
Tangible Book Value Per Share₹322.62
Margins
Gross margin is 65.83%, with operating margin of 41.00%, and net profit margin of 8.25%.
Gross Margin65.83%
Operating Margin41.00%
Pretax Margin12.63%
Net Profit Margin8.25%
EBITDA Margin18.64%
EBIT Margin14.51%
Analyst Forecast
The average price target for IPCA Laboratories Limited is ―, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target―
Price Target Upside―
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast9.66%
EPS Growth Forecast25.79%